Security key
528872302
LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX)
CUSIP: 528872302
Q4 2019 13F Holders as of 31 Dec 2019
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 107,178,320
- Total 13F value
- $444,778,336
- Share change
- +4,618,453
- Put/Call ratio
- 60%
- SEC-reported price per share
- $4.15
- Number of holders
- 110
- Value change
- +$20,431,577
- Number of buys
- 51
- Number of sells
- 42
- Shares outstanding
- 444,558,533
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2019
Institutions
110
Top holders
10
LXRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2020
Previous quarter: Q3 2019
LEXICON PHARMACEUTICALS, INC. SEC filings
LEXICON PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 528872302
Recent filing periods:
Ownership snapshot
Top reported holders of LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Artal Group S.A.
Disclosed value leader
Artal Group S.A.
Comparable rows
15/15
Latest evidence
30 Sep 2019
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
Artal Group S.A. leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Artal Group S.A.'s linked filing trail.
Comparable ownership
Top 5
Artal Group S.A.
14%
FMR LLC
2.9%
Ulys, L.L.C.
0.97%
BlackRock Finance, Inc.
0.93%
VANGUARD GROUP INC
0.69%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Artal Group S.A. |
13F
Company
|
14%
|
$181,325,000
60,240,864 shares
|
— | 30 Sep 2019 |
| FMR LLC |
13F
Company
|
2.9%
|
$39,386,000
13,084,894 shares
|
— | 30 Sep 2019 |
| Ulys, L.L.C. |
13F
Individual
|
0.97%
|
$13,007,000
4,321,214 shares
|
— | 30 Sep 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
0.93%
|
$12,475,000
4,143,943 shares
|
— | 30 Sep 2019 |
| VANGUARD GROUP INC |
13F
Company
|
0.69%
|
$9,217,000
3,061,989 shares
|
— | 30 Sep 2019 |
| Boxer Capital, LLC |
13F
Company
|
0.56%
|
$7,525,000
2,500,000 shares
|
— | 30 Sep 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
110
Shares
107,178,320
Rows available
110
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
95
Q4 2019 holders
110
Holder diff
15
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 value | Q4 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend